Formocresol pulpotomy material
Preclinical
Formocresol pulpotomy material is one of 5 therapeutic programs targeting Healing. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
4
Competitors
Pipeline
Status by Indication[2][1]
Competition
Competitive Landscape
7 competitors in Healing
#DrugCompanyPhaseTrials
1Carafate
AbbVieApproved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Psilocybin
COMPASS PathwaysPhase 1
Platelet Rich Fibrin
GGovernment Dental College and Research Institute, Bangalore
Preclinical
Formocresol pulpotomy material
FFoundation University Islamabad
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
Details
Drug Info
Quick Facts
- Highest Phase
- Preclinical[1]
- Company
- FFoundation University Islamabad